Resolution of captopril-induced rash after substitution of enalapril.
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002216:Captopril / Q000009:adverse effects*; D004151:Dipeptides / Q000627:therapeutic use*; D003875:Drug Eruptions / Q000209:etiology*; D004656:Enalapril; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011392:Proline / Q000031:analogs & derivatives*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D004151:Dipeptides; D004656:Enalapril; D011392:Proline; D002216:Captopril